Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 20, 2024Open Access

Vaccination Against Rabbit Hemorrhagic Disease Virus 2 Using a Baculovirus Recombinant Vaccine Provides Durable Immunity in Rabbits

View Full Paper
Ask AI
Bookmark
Share

Authors

ABAngela M. Bosco‐LauthASAmber SchuelerEMEdward Midthun

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bosco‐Lauth et al. (2024) studied this question.

synapsesocial.com/papers/68e78809b6db6435876fa3bfhttps://doi.org/10.20944/preprints202402.1106.v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Vaccination against Rabbit Hemorrhagic Disease Virus 2 (RHDV2) Using a Baculovirus Recombinant Vaccine Provides Durable Immunity in Rabbits2024 · 7 citations
  2. 2Molecular characterization of rabbit hemorrhagic disease virus type 2 and long-lasting protection conferred by a VLP-based vaccine2026
  3. 3Antibody response of endangered riparian brush rabbits to vaccination against rabbit hemorrhagic disease virus 22024 · 1 citations
  4. 4Field evaluation of YURVAC® RHD vaccine-induced humoral immunity in intensive meat rabbit farms2026
  5. 5Variation of rabbit serum IgA in relation to RHDV vaccination and infection: implications for serological diagnosis and epidemiological investigations2026